<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="126258">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02154074</url>
  </required_header>
  <id_info>
    <org_study_id>Dexmedetomidine 20140527</org_study_id>
    <nct_id>NCT02154074</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Influence on the Level of Perioperative Blood Glucose and Insulin of Elderly Diabetes Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital of Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital of Xi'an Jiaotong University</source>
  <oversight_info>
    <authority>China: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Dexmedetomidine is a kind of high selectivity alpha 2 agonists adrenaline, can inhibit the
      activity of sympathetic nerve, alleviate pain,and improve cardiovascular stability in the
      operation period. Dexmedetomidine have influence on perioperative stress response and immune
      function,but it is not clear.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>blood glucose</measure>
    <time_frame>from the day before surgery to 24 hours after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>measure blood glucose at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); examine the concentration of blood glucose in serum.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>level of blood insulin</measure>
    <time_frame>from the day before surgery to 24 hours after surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>measure the level of blood insulin at 3 time points,the day before surgery,Intraoperative(1 hour after surgery begain),one day after surgery(24 hours after surgery); use ELISA to examine the concentration of blood insulin in serum.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vital signs</measure>
    <time_frame>duration of perioperative period</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>measure the blood pressure(BP),heart rate(HR) and oxygen saturation(SpO2) in the perioperative period</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Perioperative Blood Glucose and Insulin</condition>
  <arm_group>
    <arm_group_label>N1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>for normal patients: inhale Isoflurane + the same volume of saline during operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>N2 group: Isoflurane &amp; Dexmedetomidine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>for normal patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>for diabetes patients: inhale Isoflurane + the same volume of saline during operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>D2 group: Isoflurane &amp; Dexmedetomidi</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>for diabetes patients: inhale Isoflurane + intravenous pumping Dexmedetomidine during operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>general anesthesia induction</intervention_name>
    <description>general anesthesia induction: midazolam 0.1mg/Kg, sufentanil 1ug/Kg, cisatracurium 0.15mg/Kg, and then immediatly administrate etomidate 0.2 mg/Kg</description>
    <arm_group_label>N1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_label>N2 group: Isoflurane &amp; Dexmedetomidine</arm_group_label>
    <arm_group_label>D1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_label>D2 group: Isoflurane &amp; Dexmedetomidi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Isoflurane</intervention_name>
    <description>inhale Isoflurane 1.5MAC</description>
    <arm_group_label>N1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_label>N2 group: Isoflurane &amp; Dexmedetomidine</arm_group_label>
    <arm_group_label>D1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_label>D2 group: Isoflurane &amp; Dexmedetomidi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>anesthesia induction period: intravenous pumping Dexmedetomidine 4ug/Kg/h; after 10 minutes,turn to 0.4ug/Kg/h.</description>
    <arm_group_label>N2 group: Isoflurane &amp; Dexmedetomidine</arm_group_label>
    <arm_group_label>D2 group: Isoflurane &amp; Dexmedetomidi</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>normal saline</intervention_name>
    <description>the same volume of saline + Isoflurane during operation</description>
    <arm_group_label>N1 group: Isoflurane &amp; saline</arm_group_label>
    <arm_group_label>D1 group: Isoflurane &amp; saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged 60 to 80 years old;

          -  Type 2 diabetes;

          -  Not use insulin treatment;

          -  Onging general anesthesia surgery;

          -  Surgery time 1-3 hours

        Exclusion Criteria:

          -  ASA classification &gt; class II;

          -  Hypertension;

          -  Serious central nervous system diseases (acute stroke, uncontrolled seizures, -Severe
             dementia);

          -  Unstable angina and acute myocardial infarction;

          -  Allergy to investigational drug;

          -  Hepatic and renal dysfunction
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hongtao Liu</last_name>
    <phone>13572225310</phone>
    <email>lannylouis@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>SecondXianJiaotongU</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongtao Liu</last_name>
      <phone>13572225310</phone>
      <email>lannylouis@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 30, 2014</lastchanged_date>
  <firstreceived_date>May 28, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dexmedetomidine perioperative blood glucose and insulin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Isoflurane</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
